HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krul, E. S. Articles by Schonfeld, G. Search for Related Content PubMed PubMed Citation Articles by Krul, E. S. Articles by Schonfeld, G. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 29, 937-947, Copyright © 1988 by Lipid Research, Inc.

ARTICLES

Regional specificities of monoclonal anti-human apolipoprotein B antibodies

ES Krul, Y Kleinman, M Kinoshita, B Pfleger, K Oida, A Law, J Scott, R Pease and G Schonfeld
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.

The usefulness of monoclonal antibodies as probes of protein structure is directly related to knowledge of the structures and locations of the epitopes with which they interact. In this report we provide a detailed map of 13 epitopes on apoB-100 defined by our anti-apoB monoclonal antibodies based on current information on the amino acid sequence of apoB-100. To localize antibody specificities to smaller regions along the linear sequence of the apoB-100 molecule we used a) thrombin- and kallikrein-generated fragments of apoB-100; b) beta-galactosidase- apoB fusion proteins; c) heparin; and d) antibody versus antibody competition experiments. Most of the monoclonal antibodies elicited by immunization with LDL were directed towards epitopes within the first 1279 amino terminal (T4/K2 fragments) or last 1292 carboxyl terminal amino acid residues (T2/K4 fragments) of apoB-100. One epitope localized to the mid-portion of apoB-100 was elicited by immunization with VLDL (D7.2). Saturating amounts of heparin bound to LDL did not inhibit the binding of any of the monoclonal antibodies to their respective epitopes on apoB-100, indicating that none of the antibody determinants is situated close to any of the reported heparin binding sites on LDL apoB. We examined the expression of apoB epitopes on VLDL subfractions and LDL isolated from a normolipidemic donor. The apparent affinities with which the antibodies interacted with their respective epitopes on the VLDL subfractions and LDL uniformly increased as follows: LDL greater than VLDL3 greater than VLDL2 greater than VLDL1, suggesting that each of the major regions of apoB-100 is progressively more exposed as normal VLDL particles become smaller in size and epitopes are most exposed in LDL. Previous experiments utilizing hypertriglyceridemic VLDL subfractions yielded similar results, but the rank order of VLDL subfractions and LDL was not the same for all antibodies tested. Thus, differences in apoB epitope expression on VLDL particles of differing sizes is a general phenomenon, but the expression of apoB epitopes in hypertriglyceridemic VLDL appears to be more heterogeneous than is the case for VLDL from normolipidemic donors.(ABSTRACT TRUNCATED AT 400 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. L. Dixon, J. Biddle, C.-m. Lo, J. D. Stoops, H. Li, N. Sakata, and T. E. Phillips Apolipoprotein B Is Synthesized in Selected Human Non-hepatic Cell Lines But Not Processed into Mature Lipoprotein J. Histochem. Cytochem., May 1, 2002; 50(5): 629 - 640. [Abstract] [Full Text] [PDF]

				N. Sakata, T. E. Phillips, and J. L. Dixon Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells J. Lipid Res., December 1, 2001; 42(12): 1947 - 1958. [Abstract] [Full Text] [PDF]

				N. Sakata, J. D. Stoops, and J. L. Dixon Cytosolic Components Are Required for Proteasomal Degradation of Newly Synthesized Apolipoprotein B in Permeabilized HepG2 Cells J. Biol. Chem., June 11, 1999; 274(24): 17068 - 17074. [Abstract] [Full Text] [PDF]

				R. A. K. Srivastava, N. Srivastava, M. Averna, A. B. Cefalu, and G. Schonfeld Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene J. Lipid Res., May 1, 1999; 40(5): 901 - 912. [Abstract] [Full Text]

				J. Wu, J. Kim, Q. Li, P.-Y. Kwok, T. G. Cole, B. Cefalu, M. Averna, and G. Schonfeld Known mutations of apoB account for only a small minority of hypobetalipoproteinemia J. Lipid Res., May 1, 1999; 40(5): 955 - 959. [Abstract] [Full Text]

				X. Du, J. Daniel Stoops, J. R. Mertz, C. Michael Stanley, and J. L. Dixon Identification of Two Regions in Apolipoprotein B100 that are Exposed on the Cytosolic Side of the Endoplasmic Reticulum Membrane J. Cell Biol., May 4, 1998; 141(3): 585 - 599. [Abstract] [Full Text] [PDF]

				H. L. Dichek, W. Brecht, J. Fan, Z.-S. Ji, S. P. A. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, et al. Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins. EVIDENCE THAT HEPATIC LIPASE ACTS AS A LIGAND FOR LIPOPROTEIN UPTAKE J. Biol. Chem., January 23, 1998; 273(4): 1896 - 1903. [Abstract] [Full Text] [PDF]

				S. P. A. McCormick, J. K. Ng, C. M. Cham, S. Taylor, S. M. Marcovina, J. P. Segrest, R. E. Hammer, and S. G. Young Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a) J. Biol. Chem., September 19, 1997; 272(38): 23616 - 23622. [Abstract] [Full Text] [PDF]

				X.-F. Zhu, D. Noto, R. Seip, A. Shaish, and G. Schonfeld Organ Loci of Catabolism of Short Truncations of ApoB Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1032 - 1038. [Abstract] [Full Text]

				S. B. Patel and S. M. Grundy Interactions between Microsomal Triglyceride Transfer Protein and Apolipoprotein B within the Endoplasmic Reticulum in a Heterologous Expression System J. Biol. Chem., August 2, 1996; 271(31): 18686 - 18694. [Abstract] [Full Text] [PDF]

				D. G. Gretch, S. L. Sturley, L. Wang, B. A. Lipton, A. Dunning, K. A. A. Grunwald, J. R. Wetterau, Z. Yao, P. Talmud, and A. D. Attie The Amino Terminus of Apolipoprotein B Is Necessary but Not Sufficient for Microsomal Triglyceride Transfer Protein Responsiveness J. Biol. Chem., April 12, 1996; 271(15): 8682 - 8691. [Abstract] [Full Text] [PDF]

				M. Averna, S. M. Marcovina, D. Noto, T. G. Cole, E. S. Krul, and G. Schonfeld Familial Hypobetalipoproteinemia Is Not Associated With Low Levels of Lipoprotein(a) Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2165 - 2175. [Abstract] [Full Text]

				J. Fan, S. P.A. McCormick, R. M. Krauss, S. Taylor, R. Quan, J. M. Taylor, and S. G. Young Overexpression of Human Apolipoprotein B-100 in Transgenic Rabbits Results in Increased Levels of LDL and Decreased Levels of HDL Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1889 - 1899. [Abstract] [Full Text]

				M. Ilmonen, T. Helio, R. Butler, A. Palotie, P. Pietinen, J. K. Huttunen, and M. J. Tikkanen Two New Immunogenetic Polymorphisms of the ApoB Gene and Their Effect on Serum Lipid Levels and Responses to Changes in Dietary Fat Intake Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1287 - 1293. [Abstract] [Full Text]

				S. Y. Choi, P. Sivaram, D. E. Walker, L. K. Curtiss, D. G. Gretch, S. L. Sturley, A. D. Attie, R. J. Deckelbaum, and I. J. Goldberg Lipoprotein Lipase Association with Lipoproteins Involves Protein-Protein Interaction with Apolipoprotein B J. Biol. Chem., April 7, 1995; 270(14): 8081 - 8086. [Abstract] [Full Text] [PDF]